Page results
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
UCLH vision, values and strategy
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page explains what an intra-oral scanner is and what it is used for.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
File results
-
FOI/2024/0758 - Theatre management and scheduling system
-
FOI/2024/0748 - Number of women who used maternity services for 2021-2023 (including antenatal/ labour/ birth/ post-natal care). Maternity services budget
-
FOI/2024/0761 - Nursing agencies list/ off-framework agencies and spend data 2023/24
-
FOI/2024/0814 - Asbestos Compensation 2021/22 - 2023/24
-
FOI/2024/0981 - Asbestos Containing Materials (ACMs)/ asbestos register/ asbestos management
-
FOI/2024/0835 - North Central London Cancer Alliance, breast cancer PSFU pathway
-
FOI/2024/0904 - Multiple Myeloma treatments
-
Patient diagnosis, referral, treatment for Essential Tremor/Deep Brain Stimulation/MR-guided Focused Ultrasound (MRgFUS)
-
FOI/2025/0404 - Patients referred for X-Ray and/or MRI scans from A&E for 2021, 2022, 2023, 2024
-